The partnership will provide safety net clinics that serve large HIV positive populations with real-time medication adherence data through PatchRx's patented smart pill bottle caps, integrated ...

For patients with HIV, many factors may influence medication adherence throughout multiple points of their disease course.

Uganda has made major strides in reducing the number of infants born with HIV, but persistent challenges remain in achieving ...

supporting its value in HIV ARV medication adherence studies (Nieuwkerk and Oort 2005; Simoni et al. 2006). An obstacle to progress in the HIV ARV medication adherence field has been the absence ...

Many patients with HIV have untreated anxiety symptoms, and findings show that viral suppression is worst in patients with untreated moderate-to-severe anxiety.

A new WHO report sheds light on the latest advancements in optimizing second- and third-line HIV treatment. The comprehensive ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

Uganda's efforts to combat the HIV/AIDS epidemic have made significant strides, yet crucial gaps remain, particularly in preventing mother-to-child transmission of the virus. According to latest ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...